• Return to Headlines

Albany Molecular Research has the Highest EBITDA Growth in the Life Sciences Tools & Services Industry (AMRI, BIO, QGEN, LMNX, BRKR)

By Nick Russo

Below are the three companies in the Life Sciences Tools & Services industry with the highest EBITDA Growth (next year estimate vs. LTM). EBITDA Growth can be valuable in predicting future cash flow generation and earnings power.

Albany Molecular Research ranks highest with a EBITDA growth of 369.8%. Bio-Rad Laboratories is next with a EBITDA growth of 82.3%. QIAGEN ranks third highest with a EBITDA growth of 69.6%.

Luminex follows with a EBITDA growth of 42.8%, and Bruker rounds out the top five with a EBITDA growth of 37.6%.

SmarTrend recommended that subscribers consider buying shares of Bio-Rad Laboratories on July 12th, 2016 as our technology indicated a new Uptrend was in progress when shares hit $144.77. Since that recommendation, shares of Bio-Rad Laboratories have risen 57.0%. We continue to monitor Bio-Rad Laboratories for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: highest ebitda growth albany molecular research bio-rad laboratories qiagen luminex bruker

Ticker(s): AMRI BIO QGEN LMNX BRKR